Hyperlactataemia and hepatic steatosis: mitochondrial toxicity of nucleoside reverse transcriptase inhibitors

Similar Items

• Mitochondrial toxicities of nucleoside analogue reverse transcriptase inhibitors in AIDS cases
  od: Marfatia, Yogesh S., i dr.
  Izdano: (2014)
• In Vitro Mitochondrial Toxicity of Metacavir, a New Nucleoside Reverse Transcriptase Inhibitor for Treatment of Hepatitis B Virus
  od: Zhang, Pinghu, i dr.
  Izdano: (2010)
• Non-nucleoside reverse transcriptase inhibitor efavirenz activates PXR to induce hypercholesterolemia and hepatic steatosis
  od: Gwag, Taesik, i dr.
  Izdano: (2019)
• Tempol Protects Cardiomyocytes from Nucleoside Reverse Transcriptase Inhibitor-Induced Mitochondrial Toxicity
  od: Liu, Yongmin, i dr.
  Izdano: (2014)
• Abstracts from the current global literature: Mitochondrial toxicities due to nucleoside reverse transcriptase inhibitors
  od: Jain, Sonia, i dr.
  Izdano: (2012)